Clarus Therapeutics Holdings (CRXT) Stock Forecast for 2024–2028. Sell or Buy Prediction







6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Getting A Kredittkort Norge Approval Isn’t Difficult

February 8, 2024 Getting A Kredittkort Norge Approval Isn’t Difficult

If you meet the conditions, you can open an account for checking in Norway. However, it will be much easier and more convenient…

Clarus Therapeutics Holdings (CRXT) Stock Forecast for 2024–2028. Sell or Buy?

Updated: March 19, 2024 (06:53)

Sector: Healthcare

The share price of Clarus Therapeutics Holdings, Inc. (CRXT) now

Latest session on the 6th of March for
Clarus Therapeutics Holdings, Inc. is negative
Trading Volume: 0
Open: 0.001 /  High: 0.001 /  Low: 0.001
What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Clarus Therapeutics Holdings stocks, the 50-day moving average is the support level today.

For Clarus Therapeutics Holdings stocks, the 200-day moving average is the support level today.

Are you interested in Clarus Therapeutics Holdings, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Clarus Therapeutics Holdings stock price in 2024, 2025, 2026, 2027, 2028. How much will one Clarus Therapeutics Holdings share be worth in 2024 - 2028?

When should I take profit in Clarus Therapeutics Holdings stock? When should I record a loss on Clarus Therapeutics Holdings stock? What are analysts' forecasts for Clarus Therapeutics Holdings stock? What is the future of Clarus Therapeutics Holdings stock? We forecast Clarus Therapeutics Holdings stock performance using neural networks based on historical data on Clarus Therapeutics Holdings stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Clarus Therapeutics Holdings stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Clarus Therapeutics Holdings shares. This happens once a day.


Historical and forecast chart of Clarus Therapeutics Holdings stock

The chart below shows the historical price of Clarus Therapeutics Holdings stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Clarus Therapeutics Holdings stock price can be found in the table below.

Long-term forecasts by years.

Clarus Therapeutics Holdings, Inc. is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. the company’s first commercial product is JATENZO. It is headquartered in Northbrook, IL.

Clarus Therapeutics Holdings daily forecast for a month

Date Target Pes. Opt. Vol., %
Mar 21 0.00 0.00 0.00 6.38
Mar 22 0.00 0.00 0.00 6.15
Mar 23 0.00 0.00 0.00 5.62
Mar 24 0.00 0.00 0.00 5.34
Mar 25 0.00 0.00 0.00 3.62
Mar 26 0.00 0.00 0.00 7.52
Mar 27 0.00 0.00 0.00 6.29
Mar 28 0.00 0.00 0.00 7.87
Mar 29 0.00 0.00 0.00 7.56
Mar 30 0.00 0.00 0.00 7.45
Mar 31 0.00 0.00 0.00 4.56
Apr 01 0.00 0.00 0.00 5.92
Apr 02 0.00 0.00 0.00 4.89
Apr 03 0.00 0.00 0.00 6.76
Apr 04 0.00 0.00 0.00 6.30
Apr 05 0.00 0.00 0.00 5.92
Apr 06 0.00 0.00 0.00 7.32
Apr 07 0.00 0.00 0.00 6.86
Apr 08 0.00 0.00 0.00 6.47
Apr 09 0.00 0.00 0.00 4.30
Apr 10 0.00 0.00 0.00 8.44
Apr 11 0.00 0.00 0.00 5.78
Apr 12 0.00 0.00 0.00 6.13
Apr 13 0.00 0.00 0.00 6.52
Apr 14 0.00 0.00 0.00 6.86
Apr 15 0.00 0.00 0.00 5.63
Apr 16 0.00 0.00 0.00 8.78
Apr 17 0.00 0.00 0.00 7.72
Apr 18 0.00 0.00 0.00 9.83
Apr 19 0.00 0.00 0.00 7.62

Clarus Therapeutics Holdings Daily Price Targets


Clarus Therapeutics Holdings Stock Forecast 03-21-2024.

Forecast target price for 03-21-2024: $0.00.
Positive dynamics for Clarus Therapeutics Holdings shares will prevail with possible volatility of 5.995%.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Clarus Therapeutics Holdings Stock Forecast 03-22-2024.

Forecast target price for 03-22-2024: $0.00.
Positive dynamics for Clarus Therapeutics Holdings shares will prevail with possible volatility of 5.789%.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Clarus Therapeutics Holdings Stock Forecast 03-23-2024.

Forecast target price for 03-23-2024: $0.00.
Negative dynamics for Clarus Therapeutics Holdings shares will prevail with possible volatility of 5.322%.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Clarus Therapeutics Holdings Stock Forecast 03-24-2024.

Forecast target price for 03-24-2024: $0.00.
Negative dynamics for Clarus Therapeutics Holdings shares will prevail with possible volatility of 5.071%.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Clarus Therapeutics Holdings Stock Forecast 03-25-2024.

Forecast target price for 03-25-2024: $0.00.
Negative dynamics for Clarus Therapeutics Holdings shares will prevail with possible volatility of 3.489%.
Pessimistic target level: 0.00
Optimistic target level: 0.00

Clarus Therapeutics Holdings Stock Forecast 03-26-2024.

Forecast target price for 03-26-2024: $0.00.
Positive dynamics for Clarus Therapeutics Holdings shares will prevail with possible volatility of 6.995%.
Pessimistic target level: 0.00
Optimistic target level: 0.00

CRXT (CRXT) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Apr. 0.00 0.00 0.00 34.05
May. 0.00 0.00 0.00 29.55
Jun. 0.00 0.00 0.00 30.28
Jul. 0.00 0.00 0.00 34.48
Aug. 0.00 0.00 0.00 25.76
Sep. 0.00 0.00 0.00 31.01
Oct. 0.00 0.00 0.00 28.02
Nov. 0.00 0.00 0.00 34.81
Dec. 0.00 0.00 0.00 35.89

Clarus Therapeutics Holdings forecast for this year


Clarus Therapeutics Holdings Stock Prediction for Apr 2024

An uptrend is forecast for this month with an optimal target price of $0.001117. Pessimistic: $0.00. Optimistic: $0.00


Clarus Therapeutics Holdings Stock Prediction for May 2024

An downtrend is forecast for this month with an optimal target price of $0.00108349. Pessimistic: $0.00. Optimistic: $0.00


Clarus Therapeutics Holdings Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $0.000953471. Pessimistic: $0.00. Optimistic: $0.00


Clarus Therapeutics Holdings Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $0.00094775. Pessimistic: $0.00. Optimistic: $0.00


Clarus Therapeutics Holdings Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $0.000785685. Pessimistic: $0.00. Optimistic: $0.00


Clarus Therapeutics Holdings Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $0.000679618. Pessimistic: $0.00. Optimistic: $0.00


Clarus Therapeutics Holdings Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $0.000581753. Pessimistic: $0.00. Optimistic: $0.00


Clarus Therapeutics Holdings Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $0.000583498. Pessimistic: $0.00. Optimistic: $0.00


Clarus Therapeutics Holdings Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $0.00066227. Pessimistic: $0.00. Optimistic: $0.00



Clarus Therapeutics Holdings (CRXT) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 0.00 0.00 0.00 25.55
Feb 0.00 0.00 0.00 26.71
Mar 0.00 0.00 0.00 18.68
Apr 0.00 0.00 0.00 25.96
May 0.00 0.00 0.00 20.42
Jun 0.00 0.00 0.00 31.15
Jul 0.00 0.00 0.00 13.64
Aug 0.00 0.00 0.00 18.57
Sep 0.00 0.00 0.00 19.04
Oct 0.00 0.00 0.00 13.80
Nov 0.00 0.00 0.00 16.06
Dec 0.00 0.00 0.00 33.64

Clarus Therapeutics Holdings (CRXT) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 0.00 0.00 0.00 31.11
Feb 0.00 0.00 0.00 38.56
Mar 0.00 0.00 0.00 22.37
Apr 0.00 0.00 0.00 27.44
May 0.00 0.00 0.00 27.84
Jun 0.00 0.00 0.00 31.78
Jul 0.00 0.00 0.00 19.70
Aug 0.00 0.00 0.00 29.42
Sep 0.00 0.00 0.00 31.06
Oct 0.00 0.00 0.00 27.34
Nov 0.00 0.00 0.00 32.33
Dec 0.00 0.00 0.00 21.43

Clarus Therapeutics Holdings (CRXT) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 0.00 0.00 0.00 28.55
Feb 0.00 0.00 0.00 30.28
Mar 0.00 0.00 0.00 24.80
Apr 0.00 0.00 0.00 17.42
May 0.00 0.00 0.00 31.71
Jun 0.00 0.00 0.00 29.36
Jul 0.00 0.00 0.00 29.89
Aug 0.00 0.00 0.00 22.76
Sep 0.00 0.00 0.00 19.59
Oct 0.00 0.00 0.00 36.63
Nov 0.00 0.00 0.00 26.28
Dec 0.00 0.00 0.00 25.05

Clarus Therapeutics Holdings (CRXT) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 0.00 0.00 0.00 24.91
Feb 0.00 0.00 0.00 23.51
Mar 0.00 0.00 0.00 31.79
Apr 0.00 0.00 0.00 26.13
May 0.00 0.00 0.00 28.62
Jun 0.00 0.00 0.00 20.38
Jul 0.00 0.00 0.00 16.97
Aug 0.00 0.00 0.00 30.67
Sep 0.00 0.00 0.00 33.56
Oct 0.00 0.00 0.00 34.11
Nov 0.00 0.00 0.00 18.39
Dec 0.00 0.00 0.00 25.10

Clarus Therapeutics Holdings information and performance

Clarus Therapeutics Holdings Address

N/A

Market Capitalization: N/A $

Market capitalization of the Clarus Therapeutics Holdings, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CRXT shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Clarus Therapeutics Holdings is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.